Home >> Research Area >>Natural Products>>Phenols>> 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

CAS# 426821-85-4

4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

Catalog No. BCN1442----Order now to get a substantial discount!

Product Name & Size Price Stock
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 5mg Please Inquire In Stock
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 10mg Please Inquire In Stock
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 20mg Please Inquire Please Inquire
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 50mg Please Inquire Please Inquire
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 100mg Please Inquire Please Inquire
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 200mg Please Inquire Please Inquire
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 500mg Please Inquire Please Inquire
4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside: 1000mg Please Inquire Please Inquire

Quality Control of 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

Number of papers citing our products

Chemical structure

4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

3D structure

Chemical Properties of 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

Cas No. 426821-85-4 SDF Download SDF
PubChem ID 91895374 Appearance Powder
Formula C22H26O12 M.Wt 482.4
Type of Compound Phenols Storage Desiccate at -20°C
Solubility Soluble in Chloroform,Dichloromethane,Ethyl Acetate,DMSO,Acetone,etc.
Chemical Name [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(4-hydroxy-3-methoxyphenoxy)oxan-2-yl]methyl 4-hydroxy-3,5-dimethoxybenzoate
SMILES COC1=CC(=CC(=C1O)OC)C(=O)OCC2C(C(C(C(O2)OC3=CC(=C(C=C3)O)OC)O)O)O
Standard InChIKey IXDFDPOPSXBXHH-QKYBYQKWSA-N
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Source of 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

The root of Dichroa febrifuga

4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 2.073 mL 10.3648 mL 20.7297 mL 41.4594 mL 51.8242 mL
5 mM 0.4146 mL 2.073 mL 4.1459 mL 8.2919 mL 10.3648 mL
10 mM 0.2073 mL 1.0365 mL 2.073 mL 4.1459 mL 5.1824 mL
50 mM 0.0415 mL 0.2073 mL 0.4146 mL 0.8292 mL 1.0365 mL
100 mM 0.0207 mL 0.1036 mL 0.2073 mL 0.4146 mL 0.5182 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

Role of ((E)-(E)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl 3-(4-hydroxy-3-methoxyphenyl) acrylate in preservation of spatial cognitive functions of rats with chronic epilepsy.[Pubmed:26379828]

Int J Clin Exp Med. 2015 Jul 15;8(7):10380-7. eCollection 2015.

The present study demonstrates the effect of ((E)-(E)-4-(4-hydroxy-3-methoxyphenyl)-2-oxobut-3-en-1-yl 3-(4-hydroxy-3-methoxyphenyl) acrylate (CA) on spatial cognitive functions of rats with lobal cerebrovascular hypoperfusion. The bilateral common carotid arteries occlusion (2VO) surgery was performed to prepare the cerebrovascular hypoperfusion rat model. The effect of CA on spatial cognitive function was analysed using Morris water maze (MWM) test prior to and after 2VO operation. Sixty rats were randomly assigned into two groups of 30 each; long-term memory (LTM) and short-term memory (STM) groups. Both the groups were further divided into 3 subgroups: control, untreated and CA treated groups. The animals received 50 mug/kg of CA for 10 weeks of 2VO operation following which all the subgroups were tested with MWM. Both the escape latency time and total distance travelled were significantly lower for control and CA treated groups compared to untreated group revealed by working memory test. The maze test performance for control and CA treated groups was found to be improved markedly. Similarly, the results from probe memory test performance revealed significant improvement for CA treated groups compared to untreated group. Therefore, CA exhibits significant effect on the spatial cognitive preservation in rats with chronic epilepsy.

7-(4-Hydroxy-3-methoxyphenyl)-1-phenyl-4E-hepten-3-one alleviates Abeta1-42 induced cytotoxicity through PI3K-mTOR pathways.[Pubmed:28131834]

Biochem Biophys Res Commun. 2017 Mar 4;484(2):365-371.

Alzheimer's disease (AD) is the most common neurodegenerative disease in the elderly. Increasing evidence has shown that beta-amyloid protein (Abeta) production is the key pathological cause of AD. 7-(4-Hydroxy-3-methoxyphenyl)-1-phenyl-4E-hepten-3-one (AO-2), a natural diarylheptanoid, is previously found to have activities in neuronal differentiation and neurite outgrowth, and its analogue shows protective effects against Abeta. In this study, we further investigated the function of AO-2 toward Abeta-induced injuries in PC12 cells and hippocampal neurons. Pretreatment of PC12 cells with AO-2 restored cell viability in a concentration-dependent manner against Abeta-induced neurotoxicity. Moreover, the Abeta stimulated apoptosis and caspase-3 activation were markedly inhibited by AO-2. We found that AO-2 prevented the downregulation of PI3K-Akt-mTOR signaling after Abeta damage, and blockade of either PI3K or mTOR activity led to the failure of AO-2 on caspase-3 inhibition. We further showed that AO-2 was protective against two devastating effects of Abeta, increased reactive oxygen species (ROS) production and dendrite injury, and this protection was also dependent on PI3K and mTOR activities. Taken together, this study showed that AO-2 acts against Abeta-induced damages in PC12 cells and hippocampal neurons through PI3K-mTOR pathways, thus providing a new neuroprotective compound which may shed light on drug development of AD.

A Review on Pharmacological Properties of Zingerone (4-(4-Hydroxy-3-methoxyphenyl)-2-butanone).[Pubmed:26106644]

ScientificWorldJournal. 2015;2015:816364.

Humans have been using natural products for medicinal use for ages. Natural products of therapeutic importance are compounds derived from plants, animals, or any microorganism. Ginger is also one of the most commonly used condiments and a natural drug in vogue. It is a traditional medicine, having some active ingredients used for the treatment of numerous diseases. During recent research on ginger, various ingredients like zingerone, shogaol, and paradol have been obtained from it. Zingerone (4-(4-hydroxy-3-methoxyphenyl)-2-butanone) is a nontoxic and inexpensive compound with varied pharmacological activities. It is the least pungent component of Zingiber officinale. Zingerone is absent in fresh ginger but cooking or heating transforms gingerol to zingerone. Zingerone closely related to vanillin from vanilla and eugenol from clove. Zingerone has potent anti-inflammatory, antidiabetic, antilipolytic, antidiarrhoeic, antispasmodic, and so forth properties. Besides, it displays the property of enhancing growth and immune stimulation. It behaves as appetite stimulant, anxiolytic, antithrombotic, radiation protective, and antimicrobial. Also, it inhibits the reactive nitrogen species which are important in causing Alzheimer's disease and many other disorders. This review is written to shed light on the various pharmacological properties of zingerone and its role in alleviating numerous human and animal diseases.

Antispasmodic and antidiarrhoeal activities of 6-(4-hydroxy-3-methoxyphenyl)-hexanonic acid from Pycnocycla spinosa Decne. exBoiss.[Pubmed:25657799]

Res Pharm Sci. 2014 Jul-Aug;9(4):279-86.

Pharmacological activities of 6-(4-hydroxy-3-methoxyphenyl)-hexanonic acid (HMPHA), a phenolic compound, isolated from the extract of Pycnocycla spinosa was investigated on ileum motility in vivo and in vitro. Ileum motility was examined by measuring charcoal movement through the gut in mice. In addition, antidiarrhoeal activity of HMPHA was assessed and compared with standard drug; loperamide (2 mg/kg) and the hydroalcoholic extract of P. spinosa (2 mg/kg). Furthermore, concentration response curve to contraction induced by acetylcholine (ACh), 5-hydroxy triptamine (5-HT) and electrical field stimulation (EFS) were obtained after incubation of ileum segment with various concentrations of HMPHA or hydroalcoholic extract of P. spinosa. HMPHA (2 mg/kg and 5 mg/kg, orally) significantly inhibited gut movements in vivo and reduced diarrhoea induced by castor oil or sulphate magnesium. In addition, HMPHA reduced ileum contraction induced by ACh (IC50=33 +/- 6 mug/ml), 5-HT (IC50=87 +/- 12 mug/ml) and EFS (IC50=36 +/- 3 mug/ml) in vitro in a concentration-dependent manner. The inhibitory effect was reversible following washing off the drug. These studies indicate that HMPHA as an active component of P. spinosa extract has significant antispasmodic and antidiarrhoeal activities and therefore, has the potential as a lead compound for further development of a new spasmolytic remedy.

Keywords:

4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside,426821-85-4,Natural Products, buy 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside , 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside supplier , purchase 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside , 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside cost , 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside manufacturer , order 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside , high purity 4-Hydroxy-3-methoxyphenyl O-beta-D-6-O-syringate-glucopyranoside

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: